This year in language AI

This Year in Language AI: Strides Towards Perfecting Language AI Communications

This year in language AI, we have followed many newsworthy developments in natural language processing (NLP), natural language generation (NLG), and natural language understanding (NLU), highlighting the most impressive trends and technological advancements in the process of machine learning (ML) for language-based applications. Throughout this discussion, our focus has been on the effectiveness of these […]

TAUS 2019: CSOFT’s CEO Shunee Yee Speaks on Past, Present, & Future of Translation & Localization

October 16-18, Singapore, TAUS 2019, Mandarin Orchard Hotel Deep in the heart of the historic Mandarin Orchard Hotel in Singapore, leaders of localization and translation companies met to discuss nothing less than the very future of the industry. Unbeknownst to guests and travelers, the hotel’s conference room hosts TAUS 2019, an event where industry giants […]

FDA approved generic drugs are essential to keeping drugs affordable

First Generic Inhaler of Advair Diskus Becomes FDA Approved

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.

CSOFT CEO Shunee Yee Speaks with CGTN About How to Win With China

As the final installment in CGTN’s special series about “Global Business in Guangzhou” covering the 2018 Fortune Global Forum, Shunee Yee discussed three major points with two other panelists – where the opportunities are for multinationals working with China, what the best way of globalizing is, and how China and its companies can better engage with the global community.